Sakharkar, Amul J.
Vetreno, Ryan P.
Zhang, Huaibo
Kokare, Dadasaheb M.
Crews, Fulton T.
Pandey, Subhash C.
Funding for this research was provided by:
National Institute on Alcohol Abuse and Alcoholism (AA-019971)
National Institute on Alcohol Abuse and Alcoholism (AA-024605)
National Institute on Alcohol Abuse and Alcoholism (AA-010005)
National Institute on Alcohol Abuse and Alcoholism (AA-013341)
National Institute on Alcohol Abuse and Alcoholism (P50 AA-022538)
National Institute on Alcohol Abuse and Alcoholism (AA020023 (NADIA project))
National Institute on Alcohol Abuse and Alcoholism (AA020024)
National Institute on Alcohol Abuse and Alcoholism (AA020022)
U.S. Department of Veterans Affairs (Merit Review Grant,I01BX000143; Senior Research Career Scientist award)
Article History
Received: 19 July 2015
Accepted: 30 January 2016
First Online: 3 March 2016
Compliance with ethical standards
:
: No biomedical financial interests or potential conflicts of interest were reported by other authors. SCP reports that a US patent application entitled “Histone acetyl transferase activators and histone deacetylase inhibitors in the treatment of alcoholism” (serial number 60/848237 filed on September 29th, 2006) is currently pending.